Notice of Effectiveness
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 24, 2024 |
| Accession Number: | 0001213900-24-034615 | |||||
| Submission Type: | POS AM | |||||
|
Attachments
Disclaimer
180 Life Sciences Corp. published this content on 24 April 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 April 2024 10:11:38 UTC.